TERT-BUTYL (3-OXOCYCLOPENTYL)METHYLCARBAMATE, 95.0%, 250mg

ethyl 4-(2-bromophenyl)-2-hydroxy-4-oxobut-2-enoate, 95%, 500mg

1-Octanol, min. 99%, for synthesis, 1L, glass packaging

2,5-Dioxopyrrolidin-1-yl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 98%, 250mg

Tazobactam;Tazobactan acid, 97.0%, 10g

3,4-Dimethoxyphenylsulfonylethanol, 98.0%, 5g

2-(5-Chloromethyl-1H-imidazol-2-yl)pyridine, 95.0%, 1g

5-AMINO-2-CHLORO-4-FLUOROBENZONITRILE, 95%, 1g

3-(4-Fluorophenoxy)phenylboronic acid, 95%, 250mg

2-Propenamide, N-[3-[2-[[2,3-difluoro-4-[4-(2-hydroxyethyl)-1-piperazinyl]phenyl]amino]-8-quinazolinyl]phenyl]-, 10mg

3-((4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)methyl)pyridine, 95.0%, 1g

3-[3-(Trifluoromethyl)phenyl]oxetan-3-amine hydrochloride, 95.0%, 500mg

Trimethyl((4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethynyl)silane, 98%, 1g